Clinical trial on serum DHA concentration by consecutive ingestion of self-emulsifying formulation or nonself-emulsifying formulation contained DHA. A randomized, double-blind, crossover study.
Not Applicable
- Conditions
- Healthy adult
- Registration Number
- JPRN-UMIN000037558
- Lead Sponsor
- FANCL Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patient with dyslipidaemia 2. Medical treatment for some diseases 3. Subjects with severe liver diseases, digestive organ diseases, kidney diseases and heart diseases 4. Sublects who are bleeding at present or danger of bleeding (serious injuries and operations, etc.) 5. Can't stop to take a supplement during the study period. 6. Difficulty in collecting blood. 7. Smoker 8. Subjects who are planned to participate in other clinical study. 9. Subjects who are judged as unsuitable for the study by the investigator for other reason.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum DHA concentration Before 1 week, 0 week, 1week, 2weeks
- Secondary Outcome Measures
Name Time Method Serum EPA concentration Before 1 week, 0 week, 1week, 2weeks